A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants
Clinical trial NCT04816513 · COMPLETED
Trial details
- NCT number
- NCT04816513
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-01-07
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.